ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Senate Confirms FDA Commissioner Von Eschenbach.

December 8, 2006

In Brief: Construction Grant Transfer To USC Approved; Illinois Director Says NCI Pushed Consortia

January 20, 1978

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

DCCP Board Approves Concepts Of $2.6 Million In New Competing Projects, $1.2 Million In Recompetitions

September 25, 1981

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

NIH funds four centers to study breast cancer and the environment.

October 17, 2003